Tribe Says Immunity Unscathed By Joining Allergan IP Suit

Law360, New York (January 12, 2018, 7:12 PM EST) -- The Saint Regis Mohawk Tribe said Friday that joining Allergan PLC's infringement litigation against generic drug companies over patents for dry-eye drug Restasis should have no impact on its sovereign immunity at the Patent Trial and Appeal Board, while asserting the board wrongly decided earlier immunity cases.

The tribe’s filing comes after the PTAB last month gave it and the generic-drug companies challenging several Restasis patents that were transferred to the tribe permission to address recent rulings in cases involving the University of Minnesota, which held the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.